These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2569816)

  • 1. A laboratory study of age-related varicella incidence and prevalence in the Czech Socialist Republic.
    Trlifajová J; Svandová E; Pokorný J; Pokorný J
    Acta Virol; 1989 Mar; 33(2):183-7. PubMed ID: 2569816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella morbidity in Czechoslovakia.
    Trlifajová J; Svandová E; Havrlantová M; Galetková A
    J Hyg Epidemiol Microbiol Immunol; 1980; 24(2):192-9. PubMed ID: 6251130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.
    Cohen DI; Davidovici BB; Smetana Z; Balicer RD; Klement E; Mendelson E; Green MS
    Infection; 2006 Aug; 34(4):208-13. PubMed ID: 16896579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.
    Alp H; Altinkaynak S; Ertekin V; Kiliçaslan B; Giiraksin A
    Health Policy; 2005 Apr; 72(1):119-24. PubMed ID: 15760704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroepidemiology of varicella-zoster in Pakistan.
    Akram DS; Qureshi H; Mahmud A; Khan AA; Kundi Z; Shafi S; N-ur-Rehman ; Olowokure B; Weil J; Bock H; Yazdani I
    Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):646-9. PubMed ID: 11414405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age related seroprevalence of antibodies to varicella in India.
    Lokeshwar MR; Agrawal A; Subbarao SD; Chakraborty MS; Ram Prasad AV; Weil J; Bock HL; Kanwal S; Shah RC; Shah N
    Indian Pediatr; 2000 Jul; 37(7):714-9. PubMed ID: 10906803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of Varicella zoster virus ELISA for oral fluid suitable for epidemiological studies.
    Talukder Y; Gopal R; Andrews N; Glenn M; Breuer J; Brown D
    J Virol Methods; 2005 Sep; 128(1-2):162-7. PubMed ID: 15961168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella seroprevalence in Turkish population in Cyprus.
    Kurugol Z; Koturoglu G; Aksit S; Ozacar T
    Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Varicella-zoster virus seroprevalence in children between 0-15 years old].
    Savaş S; Dallar Y; Arikan I; Onde U
    Mikrobiyol Bul; 2004; 38(1-2):69-75. PubMed ID: 15293904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirect haemagglutination reaction (LH)-the method of choice for the detection of anamnestic antibodies to varicella - zoster (VZ) virus.
    Trlifajová J; Ryba M; Jelĭnek J
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):101-6. PubMed ID: 177705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
    Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
    Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).
    Juffrie M; Graham RR; Tan RI; Widjaja S; Mulyadi S; Weil J; Bock HL
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):21-4. PubMed ID: 11023059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of varicella zoster virus in pregnant patients].
    Sauerbrei A; Sonntag S; Wutzler P
    Zentralbl Gynakol; 1990; 112(4):223-6. PubMed ID: 2159681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of persistence of maternal antibodies to varicella-zoster virus by indirect haemagglutination, with result control by radioimmunoassay.
    Trlifajová J; Pokorný J; Svandovă E; Ryba M
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(1):65-73. PubMed ID: 6282961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age.
    Plans P; Costa J; Espuñes J; Plasència A; Salleras L
    BJOG; 2007 Sep; 114(9):1122-7. PubMed ID: 17666097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of varicella-zoster virus infection in normal healthy individuals aged above 6 months.
    Kowitdamrong E; Pancharoen C; Thammaborvorn R; Bhattarakosol P
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S7-11. PubMed ID: 16622994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.